NVO logo

Novo Nordisk A S (NVO)$44.96

Market Cap: 305.81 BCurrency: USD

Research Snapshot

Static fundamentals, valuation context, and investor signals for Novo Nordisk A S (NVO).

HEALTHCARE
DRUG MANUFACTURERS - GENERAL

Valuation

N/A

EV/FCF, N/A FCF yield

Quality

N/A

ROIC, N/A FCF margin

Growth

N/A

5Y sales (revenue) CAGR

Balance sheet

N/A

Debt/equity, N/A current ratio

Superinvestors

4

Top: Lee Ainslie (0.9%)

Strengths to research

No strong positive screening signals were detected from the checked-in dataset.

Watchouts

  • Full metrics are not available yet for this ticker.
Annual data: 0 periods
Quarterly data: 5 periods
Stock snapshot: May 24, 2026
Static dataset: May 25, 2026

Quality Scorecard

Build-time composite score for NVO.

Grade F
0
/ 100
Compare to:
LLYJNJUNHABBVRHHBY

Peer Comparison

Target stock against 8 market-cap comparable peers.

Heat map: red worst to green best
NVO
Target
Novo Nordisk A S$305.8BN/AN/AN/AN/AN/AN/AN/AN/A
ABBVAbbVie Inc.$346.8B91.4x22.8x6.9%6.0%29.1%N/A3.7xN/A
RHHBYRoche Holding AG ADR$265.2BN/AN/AN/AN/AN/AN/AN/AN/A
RHHVFRoche Holdings AG DIV RT$263.8BN/AN/AN/AN/AN/AN/AN/AN/A
JNJJohnson & Johnson$372.9B21.2x20.0x21.8%2.7%20.9%67.9%N/AN/A
NVSNovartis AG$223.3BN/AN/AN/AN/AN/AN/AN/AN/A
MRKMerck & Co.$208.5B16.8x15.7x34.7%9.4%19.0%N/AN/AN/A
AMGNAmgen$150.6B23.8x24.2x12.2%7.6%22.0%N/A3.2xN/A
PFEPfizer Inc.$135.4B19.0x14.8x9.0%8.5%14.5%N/AN/AN/A

Financial Charts

No financial data available for NVO (annual).

4 superinvestors own NVO

Current quarter ownership and quarter-over-quarter share changes.

Superinvestor ownership
FundSharesValue% PortfolioQoQ Change
Dodge & Cox

Dodge & Cox

19,333,750$711M0.39%0.0%
Thomas Gayner

Markel Group

2,869,774$105M0.88%0.0%
Lee Ainslie

Maverick Capital

2,080,121$76M0.89%0.0%
Francois Rochon

Giverny Capital

12,400$456,0000.02%0.0%